Edition:
United States

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

134.58USD
10:08am EST
Change (% chg)

$-0.11 (-0.08%)
Prev Close
$134.69
Open
$134.93
Day's High
$135.86
Day's Low
$134.14
Volume
5,350
Avg. Vol
92,048
52-wk High
$149.00
52-wk Low
$95.21

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.58 December 11 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 45.23 46.26 43.76 52.08
Quarter Ending Mar-18 2 27.02 29.90 24.15 --
Year Ending Dec-17 5 135.81 136.89 134.40 158.06
Year Ending Dec-18 5 167.46 195.30 153.60 204.79
Earnings (per share)
Quarter Ending Dec-17 4 0.58 0.71 0.42 1.01
Quarter Ending Mar-18 2 0.56 1.03 0.09 --
Year Ending Dec-17 4 1.45 1.62 1.26 2.54
Year Ending Dec-18 4 2.47 3.98 1.88 4.17
LT Growth Rate (%) 2 27.50 30.00 25.00 48.14

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 30.91 33.38 2.46 7.96
Quarter Ending Jun-17 24.07 28.00 3.93 16.32
Quarter Ending Mar-17 31.24 29.27 1.97 6.31
Quarter Ending Dec-16 40.33 38.19 2.15 5.33
Quarter Ending Sep-16 23.13 21.62 1.51 6.53

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 45.23 45.23 46.59 46.19 52.08
Quarter Ending Mar-18 27.02 27.02 37.50 37.50 --
Year Ending Dec-17 135.81 135.81 134.55 134.22 158.06
Year Ending Dec-18 167.46 167.46 177.26 176.42 204.79

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 2 2
Quarter Ending Mar-18 0 0 0 1
Year Ending Dec-17 0 0 3 1
Year Ending Dec-18 0 0 1 3
Earnings